论文部分内容阅读
目的:定量评价庆余救心丸对冠状动脉的扩张作用。方法:对8 例在冠状动脉造影时发现冠脉功能性狭窄(冠脉痉挛)和器质性狭窄合并痉挛的患者,用庆余救心丸0.35g 舌下含服,5m in后重复冠脉造影观察扩张冠脉效果。结果:8 例中5 例为功能性狭窄,含服庆余救心丸后5m in 狭窄消失。另3 例器质性狭窄合并痉挛者,含服后有1 例冠脉血流从TIMI1 级恢复到TIMI3 级血流。另2 例狭窄程度分别减轻20% 和50% 。总有效率为100% 。结论:庆余救心丸有显著的扩张冠脉作用,本研究结果证实了该药用于治疗冠心病心绞痛是确切有效的
Objective: To quantitatively evaluate the effect of Qingyu Jiuxin Pill on coronary artery dilation. Methods: Eight patients with coronary functional stenosis (coronary fistula) and organic stenosis complicated with coronary angiography were treated with Qingyu Jiuxin Pill with sublingual dose of 0.35g and repeated coronary angiography after 5m infusion. Observe the effect of expanding the coronary artery. Results: Of the 8 patients, 5 cases were functional stenosis. After 5 years of stenosis disappeared after the treatment of Qingyu Jiuxin Pill. In the other three patients with organic stenosis and consolidation, coronary blood flow was restored from TIMI1 to TIMI3 in 1 patient after bile. The other 2 cases were reduced by 20% and 50% respectively. The total effective rate is 100%. Conclusion: Qingyu Jiuxin Pill has a significant role in the expansion of coronary artery. The results of this study confirmed that the drug is an effective and effective treatment for angina pectoris of coronary heart disease.